Association between triglyceride-glucose index and its obesity indicators with hypertension in postmenopausal women: a cross-sectional study

QR Code

Association between triglyceride-glucose index and its obesity indicators with hypertension in postmenopausal women: a cross-sectional study

BackgroundThis study explored the association between the triglyceride-glucose (TyG) index, combined with adiposity metrics, and hypertension prevalence in postmenopausal women.MethodsA cross-sectional study was conducted using data from 4,302 postmenopausal women in the National Health and Nutritio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bo Zhang, Daoli Jiang, He Ma, Huanxian Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Nutrition
Subjects:	metabolic biomarkers obesity hypertension postmenopausal health nutrition
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1623697/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Optimizing antihypertensive therapy in postmenopausal women with metabolic syndrome
by: O. N. Poryvkina, et al.
Published: (2009-06-01)

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

Hypobarotherapy and cardiovascular risk factor correction in women in early postmenopause
by: S. K. Kshnyaseva, et al.
Published: (2012-10-01)

Hypertension in periand postmenopausal women: mechanisms, management, observation
by: E. A. Polyakova, et al.
Published: (2024-02-01)

Hypertension in peri- and postmenopausal women — pathophysiological mechanisms and approaches to treatment
by: E. I. Baranova, et al.
Published: (2023-06-01)

Losartan in postmenopausal women with essential arterial hypertension
by: O. N. Tkacheva, et al.
Published: (2010-12-01)

Cardiac arrhythmia prevalence in postmenopausal women
by: N. V. Izmozherova, et al.
Published: (2011-06-01)

Can strength training modulate inflammatory markers in postmenopausal women with overweight and obesity? Evidence from a 12-week quasi-experimental study
by: Liang Tan, et al.
Published: (2025-10-01)

Age-Related Differences in Anthropometric and Lifestyle Factors Linked to Metabolic Syndrome in Women with Overweight and Obesity: A Cross-Sectional Study
by: Łuszczki E, et al.
Published: (2025-05-01)

The impact of acute morning versus evening high-intensity interval training on circulating irisin levels and metabolic parameters in overweight postmenopausal women
by: Akram Jafari, et al.
Published: (2025-09-01)

Therapeutic aspects of hormone replacement therapy in postmenopausal women with metabolic syndrome: cardiologist’s opinion
by: T. V. Adasheva, et al.
Published: (2009-08-01)

An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01)

Moexipril and arterial hypertension treatment in postmenopausal women
by: E. F. Litvinovich
Published: (2006-04-01)

Mechanistic exploration of obesity-related indicators and motor cognitive risk syndrome: a mediated effect based on C-reactive protein triglyceride glucose index
by: Zhongqiang Guo, et al.
Published: (2025-07-01)

Editorial: Nutritional indicators and implications for human health
by: Virginia Maria Muniz, et al.
Published: (2025-07-01)

Ramipril and amlodipine therapy effects on endothelial vasodilatation, metabolic profile, and arterial hypertension course in women with postmenopausal metabolic syndrome
by: A. R. Ishmanova, et al.
Published: (2010-02-01)

Moexipril in postmenopausal women with arterial hypertension
by: M. G. Glezer, et al.
Published: (2005-02-01)

OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN
by: O. V. Dobrovolskaya, et al.
Published: (2016-03-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

Effectiveness and safety of the ACE inhibitor and diuretic combination in postmenopausal women with arterial hypertension
by: G. G. Semenkova, et al.
Published: (2011-06-01)

Association analysis of the triglyceride-glucose index with carotid atherosclerotic plaques
by: Shuping CHEN, et al.
Published: (2025-06-01)

Effects of resveratrol on postmenopausal women: a systematic review and meta-analysis
by: Weidong Wu, et al.
Published: (2025-07-01)

Postmenopausal endometrial screening at primary healthcare
by: A. I. Ischenko, et al.
Published: (2016-06-01)

CORRECTION OF PSYCHO-AUTONOMIC DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION DURING POSTMENOPAUSAL PERIOD
by: G. G. Semenkova, et al.
Published: (2016-01-01)

Impact of the pathogenetic type of postmenopause on the occurrence of tumors of the female reproductive system
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN
by: I. V. Logacheva, et al.
Published: (2016-01-01)

Modern combined hormonal therapy in early postmenopause women
by: V. B. Mychka, et al.
Published: (2012-08-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Preeclampsia as a Risk Factor of Postmenopausal Cardiovascular Disease: A Cross-Sectional Study
by: Pasquale Palmiero, et al.
Published: (2025-07-01)

Evolution of some Inflammatory Parameters and Tumor necrosis factor Alpha in Iraqi Postmenopausal Women with Hypertension
by: Abeer M. Jassim, et al.
Published: (2025-07-01)

Investigating Nutritional and Health Dynamics across Stratified Profiles of Obesity
by: Stanislav Azor
Published: (2025-01-01)

ENDOMETRIOSIS IN A POSTMENOPAUSAL WOMAN
by: IGOR S. Zakharov, et al.
Published: (2017-09-01)

Age-related and postmenopausal breast cancer progression and treatment management: The significance of pro-inflammatory cytokines and CXC chemokines
by: Amin Ullah, et al.
Published: (2025-09-01)

WAYS OF MENOPAUSAL HORMONAL THERAPY IN CORRECTION OF METABOLIC DISORDERS AND ANGIOPROTECTION IN POSTMENOPAUSAL WOMEN
by: V. Yu. Khripaeva, et al.
Published: (2016-04-01)

Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01)

Association between triglyceride–glucose index and liver enzymes in adults with metabolic syndrome: a retrospective cross-sectional study
by: Raju Rana, et al.
Published: (2025-12-01)

Clinical characteristics of postmenopausal women with endometrial polyps
by: E. G. Kobaidze, et al.
Published: (2022-07-01)

Conceptual approaches to cerebral blood flow correction in postmenopausal women with arterial hypertension
by: V. V. Yakusevich, et al.
Published: (2005-04-01)

PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE
by: V. V. Yakusevich, et al.
Published: (2015-12-01)

BONE DENSITOMETRY INDICATORS IN POSTMENOPAUSAL WOMEN DEPENDING ON TNFSF11 GENE RS9594738 (C>T) POLYMORPHISM
by: E. A. MAYLYAN
Published: (2017-06-01)